{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cytostatic activity", "Drotaverine", "No-Spa\u00ae"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27879007", "DateCompleted": {"Year": "2017", "Month": "04", "Day": "17"}, "DateRevised": {"Year": "2017", "Month": "04", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "11", "Day": "23"}], "ELocationID": ["10.1002/ardp.201600289"], "Language": ["eng"], "Journal": {"ISSN": "1521-4184", "JournalIssue": {"Volume": "350", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Jan"}}, "Title": "Archiv der Pharmazie", "ISOAbbreviation": "Arch Pharm (Weinheim)"}, "ArticleTitle": "Drotaverine - a Concealed Cytostatic!", "Abstract": {"AbstractText": ["Drotaverine (also known as dihydroperparine or No-Spa<sup>\u00ae</sup> ) is an antispasmodic drug closely related to papaverin. Drotaverin also acts as a cytostatic compound for several human tumor cell lines and nonmalignant mouse fibroblasts, and EC<sub>50</sub> values as low as 3.0\u2009\u03bcM were observed in SRB assays for HT-29 human colorectal carcinoma cells. Small structural changes (e.g., aromatization, benzylic oxidation) led to a reduced activity or a complete loss of cytotoxicity. Staining of the cells with acridine orange showed the cell membrane of the dead cells to be still intact, and a slight G1/G0 arrest in the treated cells was observed after 24\u2009h. Extra annexin V-FITC/PI assays and flow cytometry revealed drotaverine mainly to act as a cytostatic and only to a minor extent as cytotoxic agent."], "CopyrightInformation": "\u00a9 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Victor-Babes-University of Medicine and Pharmacy, Timisoara, Romania."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, Victor-Babes-University of Medicine and Pharmacy, Timisoara, Romania."}], "LastName": "Pavel", "ForeName": "Ioana Z", "Initials": "IZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Martin-Luther-University Halle-Wittenberg, Organic Chemistry, Halle (Saale), Germany."}], "LastName": "Heller", "ForeName": "Lucie", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Martin-Luther-University Halle-Wittenberg, Organic Chemistry, Halle (Saale), Germany."}], "LastName": "Sommerwerk", "ForeName": "Sven", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Martin-Luther-University Halle-Wittenberg, Organic Chemistry, Halle (Saale), Germany."}], "LastName": "Loesche", "ForeName": "Anne", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chair of Oman's Medicinal Plants and Marine Natural Products, University of Nizwa, Birkat Al-Mauz, Nizwa, Sultanate of Oman."}], "LastName": "Al-Harrasi", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Martin-Luther-University Halle-Wittenberg, Organic Chemistry, Halle (Saale), Germany."}], "LastName": "Csuk", "ForeName": "Ren\u00e9", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Arch Pharm (Weinheim)", "NlmUniqueID": "0330167", "ISSNLinking": "0365-6233"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Tetrahydroisoquinolines"}, {"RegistryNumber": "98QS4N58TW", "NameOfSubstance": "drotaverin"}, {"RegistryNumber": "DAA13NKG2Q", "NameOfSubstance": "Papaverine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle Checkpoints"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Death"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Membrane"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["drug effects"], "DescriptorName": "Fibroblasts"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["analogs & derivatives", "chemistry", "pharmacology"], "DescriptorName": "Papaverine"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Tetrahydroisoquinolines"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "10", "Day": "7"}, {"Year": "2016", "Month": "11", "Day": "6"}, {"Year": "2016", "Month": "11", "Day": "7"}, {"Year": "2016", "Month": "11", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "4", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "11", "Day": "24", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27879007", "10.1002/ardp.201600289"]}}], "PubmedBookArticle": []}